Palisade Bio (STU:7NS0) Interest Expense : €-0.02 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Palisade Bio's interest expense for the three months ended in Mar. 2024 was € -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.02 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Palisade Bio's Operating Income for the three months ended in Mar. 2024 was € -3.38 Mil. Palisade Bio's Interest Expense for the three months ended in Mar. 2024 was € -0.00 Mil. Palisade Bio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Palisade Bio Interest Expense Historical Data

The historical data trend for Palisade Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Interest Expense Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.19

-2.12

-0.01

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial											-	-	-0.01	-	-

Palisade Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02 Mil.

Palisade Bio (STU:7NS0) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Palisade Bio's Interest Expense for the three months ended in Mar. 2024 was €-0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-3.38 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €0.05 Mil.

Palisade Bio's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Palisade Bio did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Palisade Bio (STU:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PALI:USA 7NS:Germany

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines